Two Sigma Advisers’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-92,921
| Closed | -$139K | – | 2312 |
|
|
2025
Q1 | $139K | Buy |
+92,921
| New | +$139K | ﹤0.01% | 2199 |
|
|
2022
Q4 | – | Sell |
-11,800
| Closed | -$162K | – | 2510 |
|
|
2022
Q3 | $162K | Sell |
11,800
-6,200
| -34% | -$85.1K | ﹤0.01% | 2242 |
|
|
2022
Q2 | $204K | Sell |
18,000
-28,400
| -61% | -$322K | ﹤0.01% | 2271 |
|
|
2022
Q1 | $619K | Sell |
46,400
-17,400
| -27% | -$232K | ﹤0.01% | 1878 |
|
|
2021
Q4 | $1.12M | Buy |
63,800
+33,600
| +111% | +$591K | ﹤0.01% | 1508 |
|
|
2021
Q3 | $959K | Buy |
30,200
+27,200
| +907% | +$864K | ﹤0.01% | 1639 |
|
|
2021
Q2 | $257K | Buy |
+3,000
| New | +$257K | ﹤0.01% | 2188 |
|
|
2020
Q4 | – | Sell |
-13,300
| Closed | -$64K | – | 2375 |
|
|
2020
Q3 | $64K | Buy |
+13,300
| New | +$64K | ﹤0.01% | 2305 |
|